BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3340339)

  • 1. Effects of short-chain fatty acids on a human colon carcinoma cell line.
    Nutr Rev; 1988 Jan; 46(1):11-2. PubMed ID: 3340339
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells.
    Velcich A; Palumbo L; Jarry A; Laboisse C; Racevskis J; Augenlicht L
    Cell Growth Differ; 1995 Jun; 6(6):749-57. PubMed ID: 7669730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium butyrate alters the response of a human colon carcinoma cell line to transforming growth factor-beta 1.
    Lewis LR; Levine AE
    Cancer Lett; 1992 Mar; 63(1):33-40. PubMed ID: 1555205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5'-nucleotidase activity.
    Navarro JM; Olmo N; Turnay J; López-Conejo MT; Lizarbe MA
    Eur J Clin Invest; 1997 Jul; 27(7):620-8. PubMed ID: 9263751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
    Ohannesian DW; Lotan D; Lotan R
    Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of sodium butyrate and hyperosmolality on the modulation of alkaline phosphatases of LoVo cells.
    Herz F; Halwer M
    Exp Cell Res; 1990 May; 188(1):50-4. PubMed ID: 2328777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate and markers of neoplastic change in the colon.
    Johnson IT
    Eur J Cancer Prev; 1995 Oct; 4(5):365-71. PubMed ID: 7496325
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
    Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
    J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29.
    Gamet L; Daviaud D; Denis-Pouxviel C; Remesy C; Murat JC
    Int J Cancer; 1992 Sep; 52(2):286-9. PubMed ID: 1521915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate and colonic cytokinetics: differences between in vitro and in vivo studies.
    Lupton JR
    Eur J Cancer Prev; 1995 Oct; 4(5):373-8. PubMed ID: 7496326
    [No Abstract]   [Full Text] [Related]  

  • 11. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY; Shamsuddin AM
    Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein expression in clonal glioma cells by sodium butyrate.
    Hong SJ; Ko LW
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Nov; 3(11):695-702. PubMed ID: 3482265
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215).
    Whitehead RH; Young GP; Bhathal PS
    Gut; 1986 Dec; 27(12):1457-63. PubMed ID: 3804021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
    Foss FM; Veillette A; Sartor O; Rosen N; Bolen JB
    Oncogene Res; 1989; 5(1):13-23. PubMed ID: 2476706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short chain fatty acids differentially modulate cellular phenotype and c-myc protein levels in primary human nonmalignant and malignant colonocytes.
    Emenaker NJ; Basson MD
    Dig Dis Sci; 2001 Jan; 46(1):96-105. PubMed ID: 11270800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines.
    Hague A; Paraskeva C
    Eur J Cancer Prev; 1995 Oct; 4(5):359-64. PubMed ID: 7496324
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of butyrate-induced differentiation of HT-29 human colon carcinoma cells by 1,25-dihydroxyvitamin D3.
    Tanaka Y; Bush KK; Klauck TM; Higgins PJ
    Biochem Pharmacol; 1989 Nov; 38(21):3859-65. PubMed ID: 2688649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of polar organic compounds on gynecologic cancers.
    Kan YY; Ng HT; Chao KC; Ho DM; Wong H; Cheung YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Sep; 42(3):175-84. PubMed ID: 3224317
    [No Abstract]   [Full Text] [Related]  

  • 19. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
    J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of glutathione level during butyrate-induced differentiation in human colon derived HT-29 cells.
    Benard O; Balasubramanian KA
    Mol Cell Biochem; 1997 May; 170(1-2):109-14. PubMed ID: 9144324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.